Health
Study elucidates the mode of action of SGLT2 inhibitors in diabetes – News-Medical.Net
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown.
Although SGLT-2 inhibitors are central to the treatment of diabetes, their exact mode of action was hitherto unknown. In a study conducted by a research group led by Peter Wolf, Martin Krssak and Michael Krebs from MedUni Vienna’s Department of Medicine III, magnetic resonance spectroscopy (MRS) was used to show that there is a direct correlation between the elimination of glucose via the kidneys and new glucose production in the liver.
A single dose of the SGLT-2 inhibitor dapagliflozin gives rise…
-
General20 hours agoGymnastics club in Berwick shuts down following child safety complaint
-
Noosa News23 hours agoSanta drops in for carols
-
General14 hours agoAshes engulfed by fresh DRS controversy as TV umpire gives Jamie Smith out despite RTS ‘murmur’
-
Noosa News18 hours agoMeticulously crafted home in heart of Noosa Heads